nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP3A4—Fingolimod—multiple sclerosis	0.101	0.186	CbGbCtD
Ramelteon—CYP2C19—Prednisone—multiple sclerosis	0.0816	0.15	CbGbCtD
Ramelteon—CYP3A4—Methylprednisolone—multiple sclerosis	0.0651	0.12	CbGbCtD
Ramelteon—CYP2C19—Dexamethasone—multiple sclerosis	0.051	0.0937	CbGbCtD
Ramelteon—Blood cortisol decreased—Triamcinolone—multiple sclerosis	0.0505	0.293	CcSEcCtD
Ramelteon—CYP3A4—Triamcinolone—multiple sclerosis	0.0494	0.0907	CbGbCtD
Ramelteon—CYP3A4—Mitoxantrone—multiple sclerosis	0.0475	0.0874	CbGbCtD
Ramelteon—CYP3A4—Betamethasone—multiple sclerosis	0.0424	0.0779	CbGbCtD
Ramelteon—CYP3A4—Prednisolone—multiple sclerosis	0.0418	0.0768	CbGbCtD
Ramelteon—CYP3A4—Prednisone—multiple sclerosis	0.0395	0.0725	CbGbCtD
Ramelteon—CYP3A4—Dexamethasone—multiple sclerosis	0.0246	0.0453	CbGbCtD
Ramelteon—Influenza—Fingolimod—multiple sclerosis	0.0054	0.0312	CcSEcCtD
Ramelteon—Depression—Fingolimod—multiple sclerosis	0.0048	0.0278	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00284	0.0165	CcSEcCtD
Ramelteon—Fatigue—Fingolimod—multiple sclerosis	0.00265	0.0153	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.0024	0.0139	CcSEcCtD
Ramelteon—Asthenia—Fingolimod—multiple sclerosis	0.0022	0.0127	CcSEcCtD
Ramelteon—Diarrhoea—Fingolimod—multiple sclerosis	0.0021	0.0122	CcSEcCtD
Ramelteon—Dizziness—Fingolimod—multiple sclerosis	0.00203	0.0117	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00197	0.0114	CcSEcCtD
Ramelteon—Headache—Fingolimod—multiple sclerosis	0.00192	0.0111	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00187	0.0108	CcSEcCtD
Ramelteon—Arthralgia—Cladribine—multiple sclerosis	0.00181	0.0105	CcSEcCtD
Ramelteon—Myalgia—Cladribine—multiple sclerosis	0.00181	0.0105	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00181	0.0105	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00181	0.0105	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00165	0.00953	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00165	0.00953	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00159	0.00918	CcSEcCtD
Ramelteon—Insomnia—Cladribine—multiple sclerosis	0.00157	0.00911	CcSEcCtD
Ramelteon—Somnolence—Cladribine—multiple sclerosis	0.00155	0.00895	CcSEcCtD
Ramelteon—Influenza—Triamcinolone—multiple sclerosis	0.00152	0.00878	CcSEcCtD
Ramelteon—Fatigue—Cladribine—multiple sclerosis	0.0015	0.00868	CcSEcCtD
Ramelteon—Arthralgia—Azathioprine—multiple sclerosis	0.00148	0.00854	CcSEcCtD
Ramelteon—Myalgia—Azathioprine—multiple sclerosis	0.00148	0.00854	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00141	0.00816	CcSEcCtD
Ramelteon—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00137	0.00794	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.00129	0.00746	CcSEcCtD
Ramelteon—Asthenia—Cladribine—multiple sclerosis	0.00125	0.00723	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.0012	0.00693	CcSEcCtD
Ramelteon—Myalgia—Mitoxantrone—multiple sclerosis	0.00119	0.00691	CcSEcCtD
Ramelteon—Arthralgia—Mitoxantrone—multiple sclerosis	0.00119	0.00691	CcSEcCtD
Ramelteon—Diarrhoea—Cladribine—multiple sclerosis	0.00119	0.00689	CcSEcCtD
Ramelteon—Dizziness—Cladribine—multiple sclerosis	0.00115	0.00666	CcSEcCtD
Ramelteon—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00114	0.00662	CcSEcCtD
Ramelteon—Headache—Cladribine—multiple sclerosis	0.00109	0.00631	CcSEcCtD
Ramelteon—Depression—Prednisone—multiple sclerosis	0.00107	0.00617	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00104	0.00603	CcSEcCtD
Ramelteon—Dysgeusia—Triamcinolone—multiple sclerosis	0.00104	0.00599	CcSEcCtD
Ramelteon—Nausea—Cladribine—multiple sclerosis	0.00103	0.00598	CcSEcCtD
Ramelteon—Somnolence—Mitoxantrone—multiple sclerosis	0.00102	0.00589	CcSEcCtD
Ramelteon—Fatigue—Mitoxantrone—multiple sclerosis	0.000986	0.00571	CcSEcCtD
Ramelteon—Diarrhoea—Azathioprine—multiple sclerosis	0.000968	0.0056	CcSEcCtD
Ramelteon—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000938	0.00543	CcSEcCtD
Ramelteon—Dizziness—Azathioprine—multiple sclerosis	0.000936	0.00542	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000931	0.00539	CcSEcCtD
Ramelteon—Myalgia—Triamcinolone—multiple sclerosis	0.0009	0.00521	CcSEcCtD
Ramelteon—Myalgia—Methylprednisolone—multiple sclerosis	0.000898	0.0052	CcSEcCtD
Ramelteon—Arthralgia—Methylprednisolone—multiple sclerosis	0.000898	0.0052	CcSEcCtD
Ramelteon—Depression—Methotrexate—multiple sclerosis	0.000891	0.00516	CcSEcCtD
Ramelteon—Headache—Azathioprine—multiple sclerosis	0.000886	0.00513	CcSEcCtD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000876	0.00309	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—PTGER4—multiple sclerosis	0.000869	0.00307	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000869	0.00307	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000869	0.00307	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000869	0.00307	CbGpPWpGaD
Ramelteon—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000863	0.005	CcSEcCtD
Ramelteon—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000861	0.00498	CcSEcCtD
Ramelteon—Insomnia—Prednisolone—multiple sclerosis	0.000849	0.00491	CcSEcCtD
Ramelteon—Nausea—Azathioprine—multiple sclerosis	0.00084	0.00486	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CXCR3—multiple sclerosis	0.000839	0.00296	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000839	0.00296	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000828	0.00292	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000828	0.00292	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—RGS1—multiple sclerosis	0.000826	0.00291	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000826	0.00291	CbGpPWpGaD
Ramelteon—Asthenia—Mitoxantrone—multiple sclerosis	0.000821	0.00475	CcSEcCtD
Ramelteon—Myalgia—Dexamethasone—multiple sclerosis	0.000817	0.00473	CcSEcCtD
Ramelteon—Myalgia—Betamethasone—multiple sclerosis	0.000817	0.00473	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—CCR2—multiple sclerosis	0.000816	0.00288	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000816	0.00288	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000806	0.00285	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000806	0.00285	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000789	0.00278	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000789	0.00278	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000786	0.00455	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000784	0.00454	CcSEcCtD
Ramelteon—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000783	0.00453	CcSEcCtD
Ramelteon—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000783	0.00453	CcSEcCtD
Ramelteon—MTNR1B—GPCR downstream signaling—GPR65—multiple sclerosis	0.000783	0.00276	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000783	0.00276	CbGpPWpGaD
Ramelteon—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000782	0.00453	CcSEcCtD
Ramelteon—Insomnia—Triamcinolone—multiple sclerosis	0.00078	0.00452	CcSEcCtD
Ramelteon—Insomnia—Methylprednisolone—multiple sclerosis	0.000779	0.00451	CcSEcCtD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000778	0.00275	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000778	0.00275	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000767	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000767	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000753	0.00266	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CNR1—multiple sclerosis	0.000753	0.00266	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—RGS1—multiple sclerosis	0.00075	0.00265	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—RGS1—multiple sclerosis	0.00075	0.00265	CbGpPWpGaD
Ramelteon—Fatigue—Triamcinolone—multiple sclerosis	0.000744	0.00431	CcSEcCtD
Ramelteon—Fatigue—Methylprednisolone—multiple sclerosis	0.000742	0.0043	CcSEcCtD
Ramelteon—Headache—Mitoxantrone—multiple sclerosis	0.000716	0.00415	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000716	0.00253	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000716	0.00253	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCR1—multiple sclerosis	0.000716	0.00253	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000716	0.00253	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000713	0.00413	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000713	0.00413	CcSEcCtD
Ramelteon—Myalgia—Prednisone—multiple sclerosis	0.000711	0.00412	CcSEcCtD
Ramelteon—Arthralgia—Prednisone—multiple sclerosis	0.000711	0.00412	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—GPR65—multiple sclerosis	0.000711	0.00251	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000711	0.00251	CbGpPWpGaD
Ramelteon—Insomnia—Dexamethasone—multiple sclerosis	0.000708	0.0041	CcSEcCtD
Ramelteon—Insomnia—Betamethasone—multiple sclerosis	0.000708	0.0041	CcSEcCtD
Ramelteon—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000708	0.0025	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000691	0.00244	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000691	0.00244	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—LINGO1—multiple sclerosis	0.000687	0.00243	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—LINGO1—multiple sclerosis	0.000687	0.00243	CbGpPWpGaD
Ramelteon—Dysgeusia—Methotrexate—multiple sclerosis	0.000684	0.00396	CcSEcCtD
Ramelteon—Anaphylactic shock—Prednisone—multiple sclerosis	0.000682	0.00395	CcSEcCtD
Ramelteon—Nausea—Mitoxantrone—multiple sclerosis	0.000679	0.00393	CcSEcCtD
Ramelteon—MTNR1A—G alpha (i) signalling events—POMC—multiple sclerosis	0.000679	0.0024	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—POMC—multiple sclerosis	0.000679	0.0024	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000678	0.00239	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000678	0.00239	CbGpPWpGaD
Ramelteon—Fatigue—Betamethasone—multiple sclerosis	0.000675	0.00391	CcSEcCtD
Ramelteon—Fatigue—Dexamethasone—multiple sclerosis	0.000675	0.00391	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—CCR1—multiple sclerosis	0.00065	0.00229	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.00065	0.00229	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.00065	0.00229	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR1—multiple sclerosis	0.00065	0.00229	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000639	0.00226	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000639	0.00226	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000621	0.0036	CcSEcCtD
Ramelteon—Dizziness—Prednisolone—multiple sclerosis	0.00062	0.00359	CcSEcCtD
Ramelteon—Asthenia—Triamcinolone—multiple sclerosis	0.000619	0.00358	CcSEcCtD
Ramelteon—Asthenia—Methylprednisolone—multiple sclerosis	0.000618	0.00358	CcSEcCtD
Ramelteon—Insomnia—Prednisone—multiple sclerosis	0.000617	0.00357	CcSEcCtD
Ramelteon—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000614	0.00217	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000596	0.0021	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TAGAP—multiple sclerosis	0.000596	0.0021	CbGpPWpGaD
Ramelteon—Arthralgia—Methotrexate—multiple sclerosis	0.000594	0.00344	CcSEcCtD
Ramelteon—Myalgia—Methotrexate—multiple sclerosis	0.000594	0.00344	CcSEcCtD
Ramelteon—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000589	0.00341	CcSEcCtD
Ramelteon—Fatigue—Prednisone—multiple sclerosis	0.000588	0.0034	CcSEcCtD
Ramelteon—Headache—Prednisolone—multiple sclerosis	0.000588	0.0034	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000584	0.00206	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCL5—multiple sclerosis	0.000584	0.00206	CbGpPWpGaD
Ramelteon—Dizziness—Triamcinolone—multiple sclerosis	0.000571	0.0033	CcSEcCtD
Ramelteon—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00057	0.0033	CcSEcCtD
Ramelteon—Dizziness—Methylprednisolone—multiple sclerosis	0.000569	0.0033	CcSEcCtD
Ramelteon—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000565	0.00199	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000565	0.00199	CbGpPWpGaD
Ramelteon—Asthenia—Dexamethasone—multiple sclerosis	0.000562	0.00325	CcSEcCtD
Ramelteon—Asthenia—Betamethasone—multiple sclerosis	0.000562	0.00325	CcSEcCtD
Ramelteon—Nausea—Prednisolone—multiple sclerosis	0.000557	0.00323	CcSEcCtD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000557	0.00197	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000557	0.00197	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00055	0.00194	CbGpPWpGaD
Ramelteon—Headache—Triamcinolone—multiple sclerosis	0.000541	0.00313	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00054	0.00191	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00054	0.00191	CbGpPWpGaD
Ramelteon—Headache—Methylprednisolone—multiple sclerosis	0.000539	0.00312	CcSEcCtD
Ramelteon—Diarrhoea—Betamethasone—multiple sclerosis	0.000536	0.0031	CcSEcCtD
Ramelteon—Diarrhoea—Dexamethasone—multiple sclerosis	0.000536	0.0031	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000528	0.00186	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000528	0.00186	CbGpPWpGaD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000527	0.00186	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCR5—multiple sclerosis	0.000526	0.00186	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000526	0.00186	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000521	0.00184	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—S1PR1—multiple sclerosis	0.000521	0.00184	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000519	0.00301	CcSEcCtD
Ramelteon—Dizziness—Betamethasone—multiple sclerosis	0.000518	0.003	CcSEcCtD
Ramelteon—Dizziness—Dexamethasone—multiple sclerosis	0.000518	0.003	CcSEcCtD
Ramelteon—Insomnia—Methotrexate—multiple sclerosis	0.000515	0.00298	CcSEcCtD
Ramelteon—Nausea—Triamcinolone—multiple sclerosis	0.000513	0.00297	CcSEcCtD
Ramelteon—Nausea—Methylprednisolone—multiple sclerosis	0.000511	0.00296	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—GPC5—multiple sclerosis	0.000507	0.00179	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GPC5—multiple sclerosis	0.000507	0.00179	CbGpPWpGaD
Ramelteon—Somnolence—Methotrexate—multiple sclerosis	0.000507	0.00293	CcSEcCtD
Ramelteon—Fatigue—Methotrexate—multiple sclerosis	0.000491	0.00284	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000491	0.00173	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000491	0.00173	CbGpPWpGaD
Ramelteon—Headache—Dexamethasone—multiple sclerosis	0.00049	0.00284	CcSEcCtD
Ramelteon—Headache—Betamethasone—multiple sclerosis	0.00049	0.00284	CcSEcCtD
Ramelteon—Asthenia—Prednisone—multiple sclerosis	0.000489	0.00283	CcSEcCtD
Ramelteon—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000486	0.00172	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000479	0.00169	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000474	0.00167	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000474	0.00167	CbGpPWpGaD
Ramelteon—Diarrhoea—Prednisone—multiple sclerosis	0.000466	0.0027	CcSEcCtD
Ramelteon—Nausea—Dexamethasone—multiple sclerosis	0.000465	0.00269	CcSEcCtD
Ramelteon—Nausea—Betamethasone—multiple sclerosis	0.000465	0.00269	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000463	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000463	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000461	0.00163	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000461	0.00163	CbGpPWpGaD
Ramelteon—Dizziness—Prednisone—multiple sclerosis	0.000451	0.00261	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.000446	0.00157	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000446	0.00157	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RGS1—multiple sclerosis	0.000443	0.00156	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RGS1—multiple sclerosis	0.000443	0.00156	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00044	0.00155	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00044	0.00155	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000434	0.00153	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000434	0.00153	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000431	0.00152	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000431	0.00152	CbGpPWpGaD
Ramelteon—Headache—Prednisone—multiple sclerosis	0.000427	0.00247	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000426	0.0015	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000426	0.0015	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GPR65—multiple sclerosis	0.00042	0.00148	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GPR65—multiple sclerosis	0.00042	0.00148	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000419	0.00148	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR2—multiple sclerosis	0.000419	0.00148	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—POMC—multiple sclerosis	0.000411	0.00145	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—POMC—multiple sclerosis	0.000411	0.00145	CbGpPWpGaD
Ramelteon—Asthenia—Methotrexate—multiple sclerosis	0.000409	0.00237	CcSEcCtD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000406	0.00143	CbGpPWpGaD
Ramelteon—Nausea—Prednisone—multiple sclerosis	0.000405	0.00234	CcSEcCtD
Ramelteon—MTNR1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000402	0.00142	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CCL2—multiple sclerosis	0.000402	0.00142	CbGpPWpGaD
Ramelteon—Diarrhoea—Methotrexate—multiple sclerosis	0.00039	0.00226	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000387	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CNR1—multiple sclerosis	0.000387	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR1—multiple sclerosis	0.000384	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL13—multiple sclerosis	0.000384	0.00136	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000384	0.00136	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR1—multiple sclerosis	0.000384	0.00136	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000383	0.00135	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000383	0.00135	CbGpPWpGaD
Ramelteon—Dizziness—Methotrexate—multiple sclerosis	0.000377	0.00218	CcSEcCtD
Ramelteon—Headache—Methotrexate—multiple sclerosis	0.000357	0.00207	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000348	0.00123	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000348	0.00123	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.00034	0.0012	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.00034	0.0012	CbGpPWpGaD
Ramelteon—Nausea—Methotrexate—multiple sclerosis	0.000338	0.00196	CcSEcCtD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000335	0.00118	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000335	0.00118	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—IL6—multiple sclerosis	0.000334	0.00118	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—IL6—multiple sclerosis	0.000334	0.00118	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.00033	0.00116	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.00033	0.00116	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCL5—multiple sclerosis	0.0003	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL5—multiple sclerosis	0.0003	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000297	0.00105	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.000297	0.00105	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000295	0.00104	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000293	0.00103	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000293	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL3—multiple sclerosis	0.000274	0.000966	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL3—multiple sclerosis	0.000274	0.000966	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR5—multiple sclerosis	0.00027	0.000953	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCR5—multiple sclerosis	0.00027	0.000953	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000266	0.000939	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000266	0.000939	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000263	0.00093	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTGER4—multiple sclerosis	0.000263	0.00093	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PGR—multiple sclerosis	0.000259	0.000916	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PGR—multiple sclerosis	0.000259	0.000916	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCR3—multiple sclerosis	0.000254	0.000898	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000254	0.000898	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CD28—multiple sclerosis	0.000252	0.00089	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CD28—multiple sclerosis	0.000252	0.00089	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR2—multiple sclerosis	0.000247	0.000874	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR2—multiple sclerosis	0.000247	0.000874	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000239	0.000844	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000237	0.000835	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000232	0.00082	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—POMC—multiple sclerosis	0.000232	0.00082	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00023	0.000812	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000228	0.000806	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CNR1—multiple sclerosis	0.000228	0.000806	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000217	0.000766	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000217	0.000766	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000211	0.000745	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—POMC—multiple sclerosis	0.000211	0.000745	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—POMC—multiple sclerosis	0.000211	0.000745	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.00021	0.000742	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000206	0.000729	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL2—multiple sclerosis	0.000206	0.000729	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000206	0.000726	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CXCL10—multiple sclerosis	0.000206	0.000726	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000187	0.000662	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—TYK2—multiple sclerosis	0.000187	0.000662	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000186	0.000658	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CD86—multiple sclerosis	0.00018	0.000635	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CD86—multiple sclerosis	0.00018	0.000635	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000177	0.000626	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL5—multiple sclerosis	0.000177	0.000625	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL5—multiple sclerosis	0.000177	0.000625	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000172	0.000606	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—IL2—multiple sclerosis	0.000172	0.000606	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000169	0.000597	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000169	0.000597	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000164	0.00058	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000164	0.000579	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SPP1—multiple sclerosis	0.000164	0.000579	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SPP1—multiple sclerosis	0.000164	0.000579	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000161	0.000568	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR5—multiple sclerosis	0.000159	0.000563	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR5—multiple sclerosis	0.000159	0.000563	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2RA—multiple sclerosis	0.000157	0.000555	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000157	0.000555	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL2—multiple sclerosis	0.000156	0.000551	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL2—multiple sclerosis	0.000156	0.000551	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000153	0.00054	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000153	0.00054	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APOE—multiple sclerosis	0.000145	0.000512	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APOE—multiple sclerosis	0.000145	0.000512	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000144	0.000508	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SRM—multiple sclerosis	0.000137	0.000484	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CD80—multiple sclerosis	0.000131	0.000463	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CD80—multiple sclerosis	0.000131	0.000463	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—POMC—multiple sclerosis	0.000127	0.000449	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—POMC—multiple sclerosis	0.000125	0.00044	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—POMC—multiple sclerosis	0.000125	0.00044	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL2—multiple sclerosis	0.000122	0.00043	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL2—multiple sclerosis	0.000122	0.00043	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000119	0.000421	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—MAPK1—multiple sclerosis	0.000119	0.000421	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TYK2—multiple sclerosis	0.000111	0.000391	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TYK2—multiple sclerosis	0.000111	0.000391	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SRM—multiple sclerosis	0.000107	0.000377	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—POMC—multiple sclerosis	9.9e-05	0.000349	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	9.66e-05	0.000341	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	9.66e-05	0.000341	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.44e-05	0.000333	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL2—multiple sclerosis	9.21e-05	0.000325	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL2—multiple sclerosis	9.21e-05	0.000325	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—multiple sclerosis	9.17e-05	0.000324	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—multiple sclerosis	9.17e-05	0.000324	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPC5—multiple sclerosis	8.83e-05	0.000312	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—multiple sclerosis	8.72e-05	0.000308	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—multiple sclerosis	8.72e-05	0.000308	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SRM—multiple sclerosis	8.24e-05	0.000291	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STAT3—multiple sclerosis	7.75e-05	0.000274	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STAT3—multiple sclerosis	7.75e-05	0.000274	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—POMC—multiple sclerosis	7.64e-05	0.00027	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	7.53e-05	0.000266	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	7.53e-05	0.000266	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.36e-05	0.00026	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—RRM1—multiple sclerosis	7.32e-05	0.000258	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MYC—multiple sclerosis	7.2e-05	0.000254	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MYC—multiple sclerosis	7.2e-05	0.000254	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TGFB1—multiple sclerosis	7.19e-05	0.000254	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TGFB1—multiple sclerosis	7.19e-05	0.000254	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK1—multiple sclerosis	7.05e-05	0.000249	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK1—multiple sclerosis	7.05e-05	0.000249	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPC5—multiple sclerosis	6.88e-05	0.000243	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	5.81e-05	0.000205	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	5.81e-05	0.000205	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—RRM1—multiple sclerosis	5.7e-05	0.000201	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.68e-05	0.0002	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—multiple sclerosis	5.42e-05	0.000191	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—multiple sclerosis	5.42e-05	0.000191	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPC5—multiple sclerosis	5.31e-05	0.000188	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.88e-05	0.000172	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.45e-05	0.000157	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.42e-05	0.000156	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—RRM1—multiple sclerosis	4.4e-05	0.000155	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—BCHE—multiple sclerosis	4.2e-05	0.000148	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.8e-05	0.000134	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.47e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.28e-05	0.000116	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APOE—multiple sclerosis	2.53e-05	8.93e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.53e-05	8.92e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—POMC—multiple sclerosis	2.17e-05	7.67e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALB—multiple sclerosis	1.98e-05	6.99e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APOE—multiple sclerosis	1.97e-05	6.96e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—POMC—multiple sclerosis	1.69e-05	5.98e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALB—multiple sclerosis	1.54e-05	5.45e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APOE—multiple sclerosis	1.52e-05	5.37e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—POMC—multiple sclerosis	1.31e-05	4.61e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALB—multiple sclerosis	1.19e-05	4.21e-05	CbGpPWpGaD
